Page 9 of 11

DR7.1-2 | Fungal Infections — Graded Quiz

Graded 10 questions · Untimed · 2 attempts

Click any question card to reveal the correct answer.

Q1 DR7.2 1 pt

A 28-year-old medical student presents to the dermatology OPD with a 6-week history of hypopigmented macules on the trunk and upper arms, which became noticeable after sun exposure. Skin scrapings are taken and examined under 20% KOH with ink. The image below is described: clustered short curved hyphae and round spore clusters on a background of squamous epithelium. She has no systemic illness. What is the MOST appropriate management?

A Topical ketoconazole 2% shampoo applied to the affected skin daily for 2 weeks, and counsel that repigmentation may take months after cure
B Oral terbinafine 250 mg/day for 4 weeks plus topical clotrimazole
C Reassurance only — this is post-inflammatory hypopigmentation that will resolve spontaneously
D Narrow-band UVB phototherapy to repigment the lesions

Correct. Tinea versicolor is caused by Malassezia, a yeast not a dermatophyte. Terbinafine (which targets dermatophytes) is NOT effective against Malassezia. Topical ketoconazole shampoo applied as a body wash is a standard, effective treatment. Counsel the patient that hypopigmentation persists for months after mycological cure — repigmentation follows sun exposure.

Pityriasis versicolor (tinea versicolor) caused by Malassezia furfur presents as hypo/hyperpigmented macules on sun-exposed trunk. KOH shows spaghetti-and-meatballs. First-line is topical antifungal (ketoconazole shampoo, selenium sulfide, or single-dose oral fluconazole/itraconazole for extensive disease). Terbinafine is NOT effective against Malassezia. Repigmentation is slow after mycological cure.

This is pityriasis versicolor (Malassezia furfur). Key trap: Terbinafine is effective against dermatophytes but NOT Malassezia. Treatment is topical ketoconazole/selenium sulfide or a single dose of oral itraconazole/fluconazole for extensive disease. Repigmentation is slow — occurs over months after successful treatment.

Click to reveal answer

Q2 DR7.1 1 pt

You are examining a KOH preparation from the nail of a 55-year-old with dystrophic toenails. The slide shows thick, irregular, branching hyphae with some budding. Your senior colleague reviews and says this is 'a high-quality mount — the only issue is you have an artefact mixed in.' The artefact they are referring to shows which feature?

A Structures that branch at acute angles and cross keratinocyte cell boundaries
B Hyphae that appear faintly green under bright-field illumination
C Budding structures adjacent to the hyphae
D Hyphae with clear septations at regular intervals

Correct. The key distinguishing feature of mosaic fungus artefact is that the refractile lines cross keratinocyte cell boundaries in a geometric pattern. True fungal hyphae respect cell boundaries. Septations, branching, and budding are genuine fungal findings, not artefacts.

Mosaic fungus artefact consists of cell wall junction lines that cross keratinocyte boundaries — true hyphae do not cross cell boundaries. They are perfectly straight, perfectly uniform in width, and form geometric grid patterns. Septa in true hyphae, branching, and budding yeast are all genuine findings.

Mosaic fungus artefact is identified by structures crossing keratinocyte cell boundaries in a straight, geometric pattern. Genuine hyphae remain within cells. Septations, branching, and budding are all real fungal features. Green fluorescence is not a standard KOH bright-field finding.

Click to reveal answer

Q3 DR7.2 1 pt

A 30-year-old pregnant woman (32 weeks gestation) presents with extensive tinea corporis unresponsive to 6 weeks of topical clotrimazole. KOH confirms septate hyphae. You decide systemic therapy is necessary. Which of the following is the MOST appropriate systemic antifungal to prescribe in this context?

A Oral terbinafine 250 mg/day for 4 weeks
B Oral itraconazole 200 mg/day for 4 weeks
C Oral fluconazole 150 mg weekly for 4 weeks
D None of the above — all systemic azoles and allylamines are avoided in pregnancy; refer to dermatologist and optimise topical regimen

Correct. No systemic antifungal used for tinea is clearly safe in pregnancy at standard doses. Itraconazole is teratogenic in animal studies; fluconazole has dose-dependent teratogenicity concerns; terbinafine has insufficient safety data. The correct approach is to optimise topical therapy (clotrimazole, miconazole, naftifine are category B/C but applied topically) and refer to a dermatologist if disease is severe.

All systemic antifungals commonly used for dermatophytosis carry significant pregnancy concerns: terbinafine (limited data, generally avoided in pregnancy), itraconazole (teratogenic in animals, avoid especially in first trimester), fluconazole (associated with fetal defects at higher doses, high-dose use restricted). For tinea in pregnancy, optimise topical therapy; if systemic therapy is unavoidable, refer to a dermatologist for specialist input.

All common systemic antifungals (terbinafine, itraconazole, fluconazole) carry significant pregnancy risk: itraconazole is teratogenic in animals, fluconazole has dose-related fetal risk, and terbinafine has insufficient data. The safe management is to maximise topical therapy and refer for specialist input. Do not prescribe systemic antifungals for tinea in pregnancy without specialist guidance.

Click to reveal answer

Q4 DR7.2 1 pt

A 10-year-old boy presents with a 3 cm boggy, painful, purulent scalp mass with overlying hair loss and multiple draining sinuses. Regional lymph nodes are enlarged. KOH of hair shows ectothrix pattern (spores on the outside of the hair shaft). What is this condition called, and what is the treatment?

A Carbuncle — incision and drainage plus oral antibiotics
B Kerion (inflammatory tinea capitis) — oral griseofulvin or terbinafine; do NOT incise and drain
C Folliculitis decalvans — long-term oral rifampicin and clindamiycin
D Tinea capitis (non-inflammatory type) — topical selenium sulfide shampoo only

Correct. Kerion celsi is an intense inflammatory mass caused by a hypersensitivity reaction to dermatophyte infection of the scalp. It is NOT a bacterial infection and should NOT be incised. Treatment: oral antifungal (griseofulvin 20 mg/kg/day or terbinafine weight-based for 6–8 weeks); add short-course oral prednisolone to reduce scarring alopecia risk.

Kerion is the severe inflammatory response to tinea capitis — a boggy, painful, sterile abscess-like mass with sinus tracts caused by a hypersensitivity reaction to dermatophyte antigens. Treatment is systemic antifungal (oral griseofulvin or terbinafine). Do NOT incise and drain (not a bacterial abscess); oral steroids may be added to reduce scarring alopecia risk.

This is kerion — an intense host immune response to tinea capitis, not a bacterial abscess. Incision and drainage is WRONG and will worsen scarring. Treatment is oral antifungal (griseofulvin or terbinafine) ± short-course steroids to prevent permanent scarring alopecia.

Click to reveal answer

Q5 DR7.2 1 pt

While reviewing a KOH mount from a vaginal discharge, you observe structures that resemble pseudohyphae — elongated chains of blastospores with visible constrictions at junction points, along with single budding yeast cells. The patient is a 25-year-old woman with thick white 'cottage cheese' vaginal discharge, vulval pruritus, and erythema. What is the COMPLETE management?

A Metronidazole 400 mg twice daily for 7 days (bacterial vaginosis treatment)
B Topical clotrimazole pessary 500 mg single dose OR oral fluconazole 150 mg single dose; treat partner only if symptomatic
C Oral terbinafine 250 mg/day for 2 weeks (covers Candida)
D No treatment; vulvovaginal candidiasis resolves spontaneously in immunocompetent patients

Correct. Vulvovaginal candidiasis is treated with single-dose intravaginal clotrimazole 500 mg or oral fluconazole 150 mg. Terbinafine is ineffective against Candida. Routine partner treatment is not recommended. Investigate for predisposing factors (diabetes, antibiotic use, immunosuppression) in recurrent cases.

Vulvovaginal candidiasis: pseudohyphae + budding yeast on KOH plus classic symptoms. Treatment: single-dose intravaginal clotrimazole 500 mg pessary OR oral fluconazole 150 mg. Terbinafine has minimal activity against Candida. Partner treatment is NOT routine (Candida is not a classic STI); treat partner only if recurrent/symptomatic.

Pseudohyphae + budding yeast = Candida, causing vulvovaginal candidiasis. Treat with single-dose intravaginal clotrimazole or oral fluconazole. Metronidazole treats bacterial vaginosis. Terbinafine does NOT cover Candida. Spontaneous resolution is unreliable and the patient needs treatment.

Click to reveal answer

Q6 DR7.2 1 pt

A 16-year-old male presents with hypopigmented annular patches on the trunk for 3 months. His classmates have similar lesions. KOH shows septate, branching hyphae. The lesions show NO fluorescence on Wood's lamp examination. Tinea corporis is confirmed. During history, he mentions he has been applying 'an OTC cream from the pharmacist' — on examination there are multiple polycyclic patches with a blurred, non-distinct border. The SINGLE most important public-health action beyond treating this patient is:

A Recommend the patient use Wood's lamp to screen classmates
B Counsel the patient to stop the steroid-antifungal combination cream, screen household contacts, and inform the school to examine symptomatic contacts
C Notify the district health officer as tinea is a notifiable disease in India
D Start all classmates on prophylactic oral terbinafine

Correct. The cluster of cases in classmates indicates person-to-person spread. The key actions are: stop the combination steroid-antifungal cream, screen household contacts and close contacts, and advise the school to examine symptomatic students. Tinea is not notifiable in India. Mass prophylaxis is not evidence-based.

Tinea corporis is contagious and spreads through contact. The public-health action is contact tracing (household members and close contacts) and screening. Topical steroid-antifungal combination cream misuse must be stopped. Tinea is not a notifiable disease in India. Mass prophylactic antifungal treatment of contacts without examination is not recommended.

The most important public-health action is contact tracing: screen household and close contacts for tinea, stop the steroid combination cream, and advise the school to examine symptomatic contacts. Tinea is NOT notifiable in India. Wood's lamp is negative for this organism (Trichophyton). Mass prophylaxis is not indicated.

Click to reveal answer

Q7 DR7.2 1 pt

A 40-year-old immunocompetent male presents with severely thickened, hyperkeratotic, crumbling nails on ALL twenty nails (finger and toenails) with hyperkeratotic skin on the palms and soles. He has never been treated. KOH is positive for septate hyphae. Which dermatophyte infection syndrome is this, and why does it affect all twenty nails?

A Chronic mucocutaneous candidiasis — T-cell immunodeficiency allows Candida to affect all nails
B Total dystrophic onychomycosis progressing from tinea pedis and tinea manuum — the 'two feet one hand' or 'one foot two hands' syndrome represents T. rubrum widespread infection
C 'Two feet, two hands, twenty nails' (TFTH) syndrome — Trichophyton rubrum infection spreading from feet to all nails and palms/soles
D Psoriatic onychodystrophy — this is not fungal infection but nail psoriasis affecting all nails

Correct. T. rubrum chronic widespread infection can involve all twenty nails along with plantar/palmar hyperkeratosis. This 'two feet two hands' TFTHN pattern is characteristic of T. rubrum chronic infection. KOH confirming septate hyphae distinguishes this from nail psoriasis. Treatment: prolonged oral terbinafine or itraconazole.

Trichophyton rubrum is the commonest dermatophyte causing chronic widespread infection. The 'two feet, two hands' (TFTHN = tinea pedis + manuum) pattern with all twenty nail involvement is a recognised syndrome of T. rubrum. The KOH confirms fungal aetiology, distinguishing it from nail psoriasis. Management requires prolonged systemic antifungal therapy.

The correct answer is the 'two feet two hands' T. rubrum syndrome. Chronic mucocutaneous candidiasis involves Candida (pseudohyphae on KOH) and is associated with immunodeficiency. KOH showing septate hyphae confirms dermatophyte, not Candida. Nail psoriasis would not show fungal elements on KOH.

Click to reveal answer

Q8 DR7.1 1 pt

You are about to perform a KOH mount on scale from a lesion you suspect is tinea cruris. You have 20% KOH available, a spirit lamp, a glass slide, cover slip, and a bright-field microscope. After placing the scale on the slide and adding a drop of KOH, what is the CORRECT next step before covering with the cover slip?

A Add a second drop of India ink to improve contrast
B Pass the slide gently over a spirit lamp flame 2-3 times to gently warm the preparation and accelerate KOH clearing
C Boil the preparation vigorously to ensure complete keratin dissolution
D Allow the slide to sit at room temperature for 24 hours before examining

Correct. Gentle warming (2-3 passes over spirit lamp) accelerates KOH clearing. Boiling destroys hyphae. Room temperature clearing takes 15-20 minutes but is acceptable. India ink is used for Cryptococcus capsule detection in CSF, not for KOH mounts.

After adding KOH to the skin scraping, gently warm the slide by passing it 2-3 times over the spirit lamp flame (do not boil). This accelerates KOH clearing of keratin without destroying fungal hyphae. The preparation can also clear at room temperature over 15-20 minutes if heating is not desired. India ink is used for Cryptococcus capsule detection, not routine KOH.

The correct technique is gentle warming over the spirit lamp (2-3 passes) to accelerate KOH clearing without boiling or destroying hyphae. Boiling destroys fungal elements. India ink is for Cryptococcus detection in CSF. Waiting 24 hours is acceptable but unnecessarily slow.

Click to reveal answer

Q9 DR7.2 1 pt

A 35-year-old female with well-controlled type 2 diabetes presents with white plaques on the oral mucosa that wipe off easily, leaving a raw bleeding surface, plus a satellite-pustule-containing rash in the axillary folds with maceration. Her blood sugar today is 8.2 mmol/L. KOH from both sites confirms Candida. Which statement about her management is MOST accurate?

A Treat oral candidiasis with nystatin suspension and axillary candidiasis with topical clotrimazole; no need to review glycaemic control as her sugar is near target
B Treat both sites with antifungals; simultaneously optimise glycaemic control as persistent hyperglycaemia is a key host factor driving Candida overgrowth
C Use oral fluconazole 150 mg single dose and this will cure both sites simultaneously
D Prioritise glycaemic control alone; candidiasis will resolve without antifungal treatment once glucose is optimised

Correct. Simultaneous antifungal therapy (topical for skin/mucosal disease; systemic if extensive) AND glycaemic optimisation is the complete management. Hyperglycaemia creates an environment favouring Candida overgrowth by impairing neutrophil function and providing excess glucose substrate. Treating only the fungus without addressing the host factor leads to recurrence.

Candidiasis in diabetics is driven by both fungal load and host immune deficiency from hyperglycaemia. Management must address both: antifungal therapy for active infection AND glycaemic optimisation to restore host defences and prevent recurrence. Neither alone is sufficient for durable cure.

Both antifungal treatment AND glycaemic optimisation are required. Treating fungus alone without correcting hyperglycaemia leads to recurrence (hyperglycaemia impairs neutrophil fungicidal activity and provides substrate for Candida). Glycaemic control alone will not cure active candidiasis fast enough. A single oral fluconazole dose is insufficient for both sites.

Click to reveal answer

Q10 DR7.2 1 pt

A dermatology registrar is counselling a 25-year-old male with extensive tinea corporis about treatment. The patient has already used two courses of topical clotrimazole (each 4 weeks) without improvement. KOH confirms septate hyphae. In the current Indian epidemiological context, which statement BEST guides the choice of systemic antifungal?

A Prescribe oral terbinafine 250 mg/day for 4 weeks as it remains the drug of first choice for all tinea in India
B Given rising terbinafine resistance (T. indotineae), prescribe oral itraconazole 200 mg/day for 4–8 weeks and counsel about steroid cream avoidance
C Prescribe oral fluconazole 150 mg weekly for 4 weeks as it has the same efficacy as terbinafine for tinea
D Perform fungal culture and sensitivity before any systemic treatment

Correct. The epidemic of terbinafine-resistant T. indotineae in India means that empiric terbinafine for recalcitrant or extensive tinea is no longer the safest choice. Itraconazole 200 mg/day for 4–8 weeks (with food, as bioavailability is enhanced by food) is the preferred systemic agent in the current context. Always counsel about stopping steroid combination creams.

India has an epidemic of terbinafine-resistant T. indotineae. Recalcitrant tinea unresponsive to topical therapy, especially in the current Indian context, should be treated empirically with itraconazole rather than terbinafine when systemic therapy is needed. Fluconazole has lower efficacy than terbinafine or itraconazole for tinea. Culture-sensitivity is ideal but impractical in routine practice.

In India's current epidemiological context, terbinafine resistance (T. indotineae) has made itraconazole the preferred systemic antifungal for recalcitrant/extensive tinea. Fluconazole has limited efficacy for dermatophytes. Culture and sensitivity is ideal but not routine practice. Option B correctly applies current Indian clinical guidelines.

Click to reveal answer